To evaluate the effi cacy of dual-energy computed tomography (CT) in the differentiation of intracerebral hemorrhage (ICH) from iodinated contrast material in patients who received contrast material via intraarterial or intravenous delivery.
This retrospective study was approved by the local institutional review board, which waived the informed consent requirement for the analysis. Sixteen patients with acute stroke and two with head trauma who had undergone intraarterial or intravenous administration of iodinated contrast material were evaluated by using dual-energy CT to differentiate areas of hyperattenuation secondary to contrast material staining from those representing ICH. A dual-energy CT scanner was used for imaging at 80 and 140 kV, and a three-material decomposition algorithm was used to obtain virtual unenhanced images and iodine overlay images. The sensitivity, specifi city, and accuracy of dual-energy CT in the prospective differentiation of intraparenchymal contrast material from hemorrhage were obtained. Follow-up images were used as the standard of reference.
Results:
There were 28 intraparenchymal areas of hyperattenuation classifi ed at dual-energy CT as iodinated contrast material staining ( n = 20, 71%), hemorrhage ( n = 5, 18%), or both ( n = 3, 11 %). Two of the three areas of hyperattenuation seen on both virtual unenhanced and iodine overlay images were related to mineralization. The sensitivity, specifi city, and accuracy of dual-energy CT in the identifi cation of hemorrhage were 100% (six of six areas), 91% (20 of 22 areas), and 93% (26 of 28 areas), respectively .
Conclusion:
Dual-energy CT can help differentiate ICH from iodinated contrast material staining with high sensitivity and specifi city in patients who have recently received intraarterial or intravenous iodinated contrast material.
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because of the lack of follow-up images. ( 1-3 ) . However, the benefi t of this treatment must be balanced against its risks, particularly posttreatment intracerebral hemorrhage (ICH). In general, ICH is more common with intraarterial therapy than with intravenous thrombolysis ( 1,2,4,5 ) and can result in signifi cant morbidity and mortality ( 2, 6 ) . Data suggest that clinically signifi cant ICH tends to occur within the fi rst 12-24 hours after treatment ( 7 ) . Furthermore, it has been demonstrated that there can be an ongoing evolution of hemorrhagic trans formation early after treatment, with some patients demonstrating marked worsening ( 8, 9 ) . Therefore, the ability to reliably identify hemorrhagic transformation immediately after therapy would allow for appropriate management (eg, discontinuation or reversal of antithrombotic medication) that may prevent hemorrhage growth ( 10, 11 ) .
Unenhanced head computed tomography (CT) is commonly performed within the fi rst 24 hours after intraarterial therapy to assess for early complications of therapy ( 12 ) and has been demonstrated to provide important prognostic information ( 13, 14 ) . Therefore, a common clinical problem is the differentiation of contrast material-related areas of hyperattenuation from acute ICH, as this may infl uence the decision to continue or initiate antiplatelet or anticoagulation therapy ( 10 ) .
The purpose of this study was to evaluate the ability of dual-energy CT to enable the differentiation of ICH from iodinated contrast material in patients who underwent contrast material administration by means of intraarterial or intravenous delivery.
Implications for Patient Care
Preliminary evidence suggests n that dual-energy CT can help reliably differentiate intraparenchymal hemorrhage from iodinated contrast material in patients who have recently received intraarterial or intravenous iodinated contrast material.
This differentiation is particularly n important immediately after intraarterial stroke therapy, especially when anticoagulation or antiplatelet therapy is being considered.
Advance in Knowledge
Dual-energy CT can help accun rately differentiate between intraparenchymal hemorrhage and iodinated contrast material staining.
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Image Analysis
Image analysis was performed in consensus by three experienced radiologists with 8 (R.G., C.M.P.) and 9 (A.J.Y.) years of experience. Among the intracerebral areas of hyperattenuation seen on the simulated 120-kV images, only intraparenchymal areas of hyperattenuation were prospectively analyzed and classifi ed as hemorrhage, contrast material, or a combination of both on the basis of the virtual unenhanced and iodine overlay images ( Table 1 ) . Imaging analysis for each case was completed before the follow-up images became available. Follow-up images from either unenhanced CT or magnetic resonance (MR) imaging were used to determine the ground truth about each area of hyperattenuation observed on the dualenergy CT scan. The fi nding of washout or near-complete clearing of the area of hyperattenuation in 24-48 hours at unenhanced CT was used as evidence that the area of hyperattenuation represented contrast material staining ( 9, 14, 17, 18 ) . If the area of hyperattenuation persisted for more than 48 hours and developed a characteristic rim of hypoattenuation (presumed to be edema or infarct), it was classifi ed as hemorrhage. The 48-hour cutoff is what we routinely use in our clinical practice. When susceptibility-weighted Dual-energy postprocessing was performed on the 1.5-mm-thick data set by using dedicated software (Syngo Dual Energy Brain Hemorrhage; Siemens Healthcare) ( 15, 16 ) that employs a threematerial decomposition algorithm based on brain parenchyma, hemorrhage, and iodine as the three preselected materials. This process is schematically shown in Figure 2 . A virtual unenhanced image and an iodine overlay image were derived from the original 80-and 140-kV data sets.
Two image sets with 4.0-and 1.5-mmthick sections were reconstructed by using H30 (medium smooth) and D37s (dual-energy, medium sharp) kernels, respectively. Each image set consisted of an 80-kV series, a 140-kV series, and a so-called "single-energy" series, which combined the 80-and 140-kV images to simulate an image obtained at 120 kV. The single-energy series has a higher signal-to-noise ratio than the constituent 80-and 140-kV image sets ( Fig 1 ) . The intercepts x and y correspond to the portion of brain parenchyma and ICH in the voxel, whereas the intercept z along the iodine axis represents the iodine content of the voxel on this two-energy plot. To the extent the measured value of a voxel does not conform to a mixture of brain parenchyma and ICH, the difference can be attributed to iodine. The virtual unenhanced images display the noniodine component of the voxel (ie, the brain parenchyma and ICH represented by x and y), and the overlay images display the z intercept (ie, the iodine content). 
Statistical Analysis
We analyzed the presence or absence of intraparenchymal hemorrhage on the dual-energy CT scans and the follow-up images (the standard of reference). Areas classifi ed as hemorrhage alone or as a combination of hemorrhage and iodine at dual-energy CT were considered positive for hemorrhage. True-positive, false-positive, true-negative, and falsenegative fi ndings were derived for the detection of ICH with dual-energy CT according to the criteria given in Table 2 . Sensitivity, specifi city, and accuracy were computed by using software (MedCalc, version 10.0; MedCalc, Mariakerke, Belgium). Table 2 Criteria 
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imaging ( Table 3 ) , as determined by means of complete washout, lack of susceptibility artifacts, or both. All fi ve areas of hyperattenuation classifi ed as hemorrhage alone with dual-energy CT were confi rmed as such on subsequent images. Of the three areas classifi ed as a combination of contrast material and hemorrhage, one was demonstrated to have a hemorrhagic component. The other two cases were found to be areas of mineralization, as determined with available previous images ( 
Discussion
Hemorrhagic transformation is a major complication of reperfusion therapy for acute ischemic stroke. Rates of symptomatic ICH obtained in the major trials of intraarterial therapy ( 2, 4, 8 ) range from 6.3% to 10.9%. Parenchymal hematomas, defi ned as ICH with associated mass effect, have been shown to have a negative effect on both short-and long-term clinical outcomes ( 6, 19 ) . Currently, unenhanced CT is the standard of care for the detection of ICH ( 20 ) and is performed soon after intraarterial therapy to assess for procedural complications. Parenchymal contrast enhancement or contrast material extravasation is a common fi nding after intraarterial therapy, occurring in 30%-50% of cases ( 9, 14, 17, 21 ) . ICH and contrast material staining may appear identical on unenhanced CT scans.
If the attenuation value of an area of hyperattenuation exceeds that expected for hemorrhage, it can be confi dently assumed that there is a component of iodinated contrast material within it. In this study, only a minority of the intraparenchymal areas of hyperattenuation ( n = 4, 16%) demonstrated such trast material staining alone ( n = 20, 71%; Fig 3 ) , hemorrhage alone ( n = 5, 18% ; Fig 4 ) , or a combination of contrast material and hemorrhage ( n = 3, 11%). All 20 areas of hyperattenuation classifi ed as contrast material alone at dual-energy CT were demonstrated to have no hemorrhage at follow-up
Results
Twenty-eight areas of intraparenchymal hyperattenuation were identifi ed on the single-energy scans. Dual-energy CT scans were evaluated according to the criteria given in Table 1 , and the areas of hyperattenuation were prospectively classifi ed as iodinated con- 
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Compton and photoelectric effects. If a hyperattenuating pixel consists of four or more materials, without any a priori knowledge, dual-energy CT cannot help differentiate the constituent materials. For example, a focus of calcifi cation (eg, skull and other areas of parafalcine and choroid plexus calcifi cation) will appear as an area of hyperattenuation on both the virtual unenhanced and iodine overlay images; such a case cannot be differentiated from a combination of hemorrhage and contrast material on the basis of the results of dual-energy CT analysis. Previously obtained images are needed to make this discrimination. Certain artifacts at CT (eg, beam hardening or metallic artifacts) may also confound dual-energy analysis. For objects with a very high attenuation (eg, undiluted contrast material) that do not change substantially between 80-and 140-kV images, dual-energy analysis may fail. All of the above situations could lead to false-negative or false-positive conclusions regarding the presence of hemorrhage. In the small cohort of patients studied herein, these potential limitations did not pose a substantial problem: Dual-energy CT enabled correct classifi cation in 26 of 28 instances of intraparenchymal hyperattenuation, with calcifi cation as the main confounder. Although this fi nding is reassuring, it may not be applicable to all possible scenarios; a larger trial is needed to determine the sensitivity, specifi city, and false-positive and/or false-negative intraarterial therapy resulting in contrast material staining and/or extravasation, the dilemma of how to treat these patients clinically is quite real. Susceptibility-weighted MR imaging remains an option for identifying the presence or absence of hemorrhage after intraarterial therapy ( 10 ) even though it is somewhat limited by availability, the presence of pacemakers and other MR imaging-incompatible devices, and the overall diffi culty of transporting an acutely sick patient to the MR imaging suite. Another option is to "simulate" a dual-energy scanner by using a single-source, single-energy scanner. If, in an axial step-and-shoot mode, 80-and 140-kV sections are obtained at each table position, one can postprocess the data set by using the dual-energy CT techniques described herein. Because these 80-and 140-kV images will be displaced in time by the time it takes for one gantry rotation, patient motion may introduce misregistration artifacts. However, on a modern gantry with a rotation time of approximately 0.27-0.33 second, this time difference may not pose a severe problem. Further scanner and appropriate postprocessing software development are necessary to clinically realize this option.
When interpreting these results, it is important to be aware of certain limitations. Dual-energy CT can only help differentiate up to three preselected materials because of fundamental physics of how attenuation is affected by the markedly elevated attenuation levels (eg, Ն 120 HU). Even in these cases, one cannot assume that there is not associated hemorrhage; for example, dual-energy CT depicted superimposed hemorrhage in one of the four cases (25%). Defi nitive identifi cation of extravascular contrast material requires serial imaging to demonstrate early washout (within 24-48 hours) in the hyperattenuating lesion ( 9, 14, 17, 18 ) . Hemorrhage is persistent over several days to weeks. This study provides a method for prospectively determining the status of each area of hyperattenuation on an unenhanced CT scan.
The tissue characterization capabilities of dual-energy CT have been previously studied (22) (23) (24) (25) (26) (27) (28) (29) (30) . In this initial study, we have demonstrated that dual-energy CT can help accurately differentiate intraparenchymal hemorrhage from iodinated contrast material staining. The discriminatory power of dual-energy CT comes at no extra cost in terms of radiation dose or image quality as compared with singleenergy unenhanced CT. Our results confi rm the fi ndings of a recent study ( 26 ) , which demonstrated that iodine could be effectively subtracted from a dual-energy CT angiogram to yield a virtual unenhanced image that rivaled traditional unenhanced CT in its diagnostic utility for hemorrhage detection.
Given the limited distribution of dual-energy CT scanners at the present time and the increasing use of Table 3 Comparison 
rates of dual-energy CT in the assessment of ICH after intraarterial therapy.
In conclusion, dual-energy CT has high sensitivity and specifi city in the differentiation of intracranial hemorrhage from iodinated contrast material staining and may be particularly helpful in patients who have recently undergone intraarterial stroke therapy.
